Click Therapeutics Clickotine
Click Therapeutics
Digital therapeutic app for smoking cessation with AI personalization
About Click Therapeutics Clickotine
Clickotine is a digital therapeutic for smoking cessation developed by Click Therapeutics. The app provides essential features aligned with US Clinical Practice Guidelines for smoking cessation, including controlled breathing exercises, personalized text messaging, social engagement features, treatment adherence tools, financial incentives, and digital diversions. The controlled breathing mechanism provides a mindful breathing experience coupled with multisensory stimuli to reduce nicotine withdrawal symptoms. The platform's machine learning system, Clickometrics, ensures the program is optimized and personalized to each user based on their profile, motivations, and daily schedules. The commercial version integrates live coaching and direct access to nicotine replacement therapy.
Best For
- • Primary care providers
- • psychiatrists
- • and addiction medicine specialists treating patients who want to quit smoking with digital support
Not Ideal For
- • Patients requiring intensive inpatient addiction treatment or those without smartphone access
Pricing
Contact for pricing
Compliance & Security
Always verify compliance directly with the vendor.
Target Audience
Roles
Settings
Related Tools
Akili Interactive (EndeavorRx, EndeavorOTC)
First FDA-cleared video game digital therapeutic for ADHD in children and adults.
Big Health (Sleepio, Daylight)
First FDA-cleared DTx for anxiety (DaylightRx) and insomnia (SleepioRx) with Medicare coverage.
Blueprint
Free EHR with AI assistant and measurement-based care for therapists.
Calm Health
Clinical wellness platform from Calm with evidence-based programs for enterprise mental health.